IPS Selected to Build a Global Rare Disease Community - September 2022

IPS launch another global community in rare diseases sector.

IPS has been selected by one of the world’s largest, rare disease pharmaceutical companies to build another global specialist community. The community will provide members with high quality information, accredited education and to collaborate and share best practice.

In addition, community members will also have the opportunity to opt-in and participate in digital advisory boards and insight gathering research.


Stay up to date with all the latest information from Interactive Pharma Solutions by signing up to our mailing list. All the latest information sent directly to your inbox.

All Rights Reserved | Copyright Interactive Pharma Solutions Ltd - Registered in England No. 09245216 - Oxford